Bariatric surgery and multidisciplinary treatment for obesity

Acta Academiae Medicinae Sinicae

Volumn 33, Issue 3, 2011, Pages 219-223

  Yu, Jian Chun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Bariatric surgery; Multidisciplinary treatment; Obesity

Indexed keywords

HORMONE;

BARIATRIC SURGERY; BEHAVIOR THERAPY; EXERCISE; GASTRIC BANDING; INTERMETHOD COMPARISON; OBESITY; REVIEW; STOMACH BYPASS; SURGICAL RISK; WEIGHT REDUCTION;

BARIATRIC SURGERY; COMBINED MODALITY THERAPY; HUMANS; OBESITY;

EID: 79960930679     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2011.03.001     Document Type: Review

References (17)

1. Hankey CR. Session 3 (Joint with the British Dietetic Association): Management of obesity: Weight-loss interventions in the treatment of obesity [J]. Proc Nutr Soc, 2010, 69 (1): 34-38.
2. Maggard MA, Shugarman LR, Suttorp M, et al. Meta analysis: surgical treatment of obesity [J]. Ann Intern Med, 2005, 142(7): 547-559.
3. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution [J]. J Clin Endocrinol Metab, 2004, 89(6): 2608-2615. (Pubitemid 38766339)
4. Boza C, Gamboa C, Awruch D, et al. Laparoscopic Rouxen-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up [J]. Surg Obes Relat Dis, 2010, 6(5): 470-475.
5. Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity [J]. Am J Manag Care, 2010, 16(7): e174-e187.
6. Ballantyne GH, Wasielewski A, Saunders JK. The surgical treatment of type II diabetes mellitus: changes in HOMA Insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB) [J]. Obes Surg, 2009, 19(9): 1297-1303.
7. Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study [J]. Arch Surg, 2011, 146(2): 149-155.
8. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial [J]. Arch Surg, 2011, 146(2): 143-148.
9. Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery [J]. Clin Endocrinol (Oxf), 2008, 69 (2): 173-179.
10. McLaughlin T, Abbasi F, Lamendola C, et al. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls [J]. J Clin Endocrinol Metab, 2004, 89(4): 1630-1635.
11. Möhlig M, Spranger J, Otto B, et al. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans [J]. J Endocrinol Invest, 2002, 25 (11): RC36-RC38.
12. Gehlert DR. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications [J]. Proc Soc Exp Biol Med, 1998, 218(1): 7-22.
13. Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels [J]. Obesity (Silver Spring), 2006, 14(9): 1553-1561. (Pubitemid 46214822)
14. Scheen AJ, De Flines J, De Roover A, et al. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives [J]. Diabetes Metab, 2009, 35(6 Pt 2): 537-543.
15. Rubino F, Gagner M, Gentileschi P. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism [J]. Ann Surg, 2004, 240(2): 236-242.
16. le Roux CW, Welboum R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass [J]. Ann Surg, 2007, 246(5): 780-785.